Entero Therapeutics
ENTO2.9900.00% ( 0.000 )
Q2 FY2025 Earnings
Financial report interval: 2025.03.30 - 2025.06.30
Overview: Entero Therapeutics(ENTO) the EBIT is -638.86 K (+81.35%);the EPS is -0.68 (+94.12%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B81.35%
----
----
EPS
-0.680294.12%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf